Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hurvitz Chaim
Director at NRX Pharmaceuticals. Filing since 16 Nov 2022.
CIK 0001630542
Company
Date
Role
Action
Shares
Amount
Of holding
NRXP
NRX Pharmaceuticals, Inc.
30 Aug 2023
Director
Bought
70,000
$20.13K
14.0%
NRXP
NRX Pharmaceuticals, Inc.
18 Nov 2022
Director
Bought
40,408
$44.45K
8.8%
NRXP
NRX Pharmaceuticals, Inc.
17 Nov 2022
Director
Bought
171,780
$185.52K
59.7%
NRXP
NRX Pharmaceuticals, Inc.
16 Nov 2022
Director
Bought
287,812
$284.93K
opened
4 decisions on file.
